Moonbase
← Back to Funding Opportunities
SAM.govDEPT OF DEFENSE — DEFENSE LOGISTICS AGENCY

Omeprazole Capsules

Posted Apr 12, 2023·open

AGENCY

DEPT OF DEFENSE

PROGRAM

Presolicitation

AMOUNT

CLOSES

Open-ended

Description

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Omeprazole. Procurement details follow. Omeprazole 20MG Capsules in 30, 90, 100, and 1000 count bottles; 40MG Capsules in 30, 90, 100, and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Indian Health Service, and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and www.SAM.gov. Interested parties should contact Ryan Ferry via email: (Ryan.Ferry@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is May of 2023. DLA reserves the right to issue the solicitation before or after the projected solicitation date.

Contact

Ryan Ferry

ryan.ferry@dla.mil

2157373182

Additional details

Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
NAICS code
325412
Archived
Apr 12, 2028

Opportunity number: SPE2D2-23-R-0011

Search this number on SAM.gov Contract Opportunities for the official listing.